• No results found

Prostate Cancer (PCa)

Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer

Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer

... castration-resistant PCa. To identify novel diagnostic and prognostic markers, we firstly investigated lncRNAs expression signature of PCa samples from patients. Another two publicly available gene ...

16

Assessment of the Performance of Specific Prostate Diagnostic Tools in the Detection of Prostate Cancer among Ghanaian Men

Assessment of the Performance of Specific Prostate Diagnostic Tools in the Detection of Prostate Cancer among Ghanaian Men

... without prostate cancer, and this is consistent with previous reports from some studies ...without prostate cancer which agrees with a cross-sectional study by Sheik et ...for prostate ...

13

Interdisciplinary decision making in prostate cancer therapy – 5-years’ time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin

Interdisciplinary decision making in prostate cancer therapy – 5-years’ time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin

... of PCa patients is the physician ...other cancer patients also exert an import- ant influence on the treatment decision ...in prostate cancer ...

9

A new predictor is comparable to the updated nomogram in predicting the intermediate- and high-risk prostate cancer but outperforms nomogram in reducing the overtreatment for the low-risk Pca

<p>A new predictor is comparable to the updated nomogram in predicting the intermediate- and high-risk prostate cancer but outperforms nomogram in reducing the overtreatment for the low-risk Pca</p>

... Korean Prostate Cancer Risk Calculator, Indonesian Prostate Cancer Risk Calculator and Prostate Cancer Prevention Trial Risk ...Chinese Prostate Cancer Consortium ...

11

Comparison of digital image analysis and visual scoring of KI-67 in prostate cancer prognosis after prostatectomy

Comparison of digital image analysis and visual scoring of KI-67 in prostate cancer prognosis after prostatectomy

... stage prostate cancer pa- ...in PCa, specifically, it was sug- gested that as few as three TMA spots were sufficient to predict PSA failure ...

10

Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancer

Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancer

... high-risk prostate cancer patients, the best course of treatment is often unclear, and the oncological out- comes appear heterogeneous among series and treat- ment ...high-risk PCa patients who ...

7

Outcomes of Patients with UnfavorableProstate Cancer Treated with High-Dose RateBrachytherapy and External BeamRadiotherapy

Outcomes of Patients with Unfavorable Prostate Cancer Treated with High-Dose Rate Brachytherapy and External Beam Radiotherapy

... in PCa is that Blacks may be more intensely exposed to deleterious nutritional factors [28], but of the few studies reporting on fiber/whole grain consumption and PCa, results have been conflicting due ...

13

A Gleason score-related outcome model for human prostate cancer: a comprehensive study based on weighted gene co-expression network analysis

A Gleason score-related outcome model for human prostate cancer: a comprehensive study based on weighted gene co-expression network analysis

... of PCa patients via protein–protein network analysis ...castration-resistant prostate cancer (CRPC) cells showed a set of homologous recombination (HR) -associ- ated genes, including BRCA1, RAD54L, ...

15

Second primary cancers after radiation for prostate cancer: A systematic review of the clinical data and impact of treatment technique

Second primary cancers after radiation for prostate cancer: A systematic review of the clinical data and impact of treatment technique

... primary cancer (SPC) is one the most serious long term con- sequences of successful cancer ...in prostate cancer (PCa) patients treated with radiotherapy, and assess whether radiation ...

16

Original Article Association of serum EPCA-2 level with prostate cancer in Chinese Han population

Original Article Association of serum EPCA-2 level with prostate cancer in Chinese Han population

... ized prostate cancer (PCa), three hundred and forty-two patients with benign prostatic hyper- plasia (BPH, diagnosis referred the AUA guide- line [11]) were recruited from Xinxiang Central Hospital ...

7

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

... Our study is the second trial worldwide investigating immune responses upon vaccination with blood-derived DCs in advanced PCa. Previously, Prue and colleagues performed a phase I trial with HLA-A*0201 peptide- ...

15

The addition of a sagittal image fusion improves the prostate cancer detection in a sensor-based MRI /ultrasound fusion guided targeted biopsy

The addition of a sagittal image fusion improves the prostate cancer detection in a sensor-based MRI /ultrasound fusion guided targeted biopsy

... Prostate cancer (PCa) is the most common malignancy of men and the only tumour, which is diagnosed according to the guidelines by untargeted systematic biopsies of the entire organ [1, ...Because ...

7

Efficacy and Safety of Androgen-Deprivation Therapy Combined with Docetaxel Plus Prednisone in High-Burden Metastatic Hormone-Sensitive Prostate Cancer

<p>Efficacy and Safety of Androgen-Deprivation Therapy Combined with Docetaxel Plus Prednisone in High-Burden Metastatic Hormone-Sensitive Prostate Cancer</p>

... therapy; PCa, prostate cancer; mHSPC, metastatic hormone-sensitive prostate cancer; mCRPC, metastatic castration resistant prostate cancer; OS, overall survival; PSA, ...

9

Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model

Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model

... in cancer, Cell cycle, Prostate cancer, and MAPK signaling path- ...of PCa and was related to the development of PCa metastases ...the prostate cancer pathway had close ...

16

Comparison Between Circulating Immune Complexes and Prostate Specific Antigen to Assess the Pathogenesis of Prostate Cancer

Comparison Between Circulating Immune Complexes and Prostate Specific Antigen to Assess the Pathogenesis of Prostate Cancer

... Prostrate cancer is a common cancer in males with increasing rate of incidence these ...and prostate specific antigen (PSA) have been used for diagnosis and in the clinical management of ...

5

Computer-aided transrectal ultrasound: does prostate HistoScanning™ improve detection performance of prostate cancer in repeat biopsies?

Computer-aided transrectal ultrasound: does prostate HistoScanning™ improve detection performance of prostate cancer in repeat biopsies?

... of prostate cancer and had at least one previous set of TRUS-guided pros- tate Bx, yielding a non-cancerous ...serum prostate-specific antigen (PSA) level >10 ng/mL, or ...for prostate ...

7

Apparent diffusion coefficient in extraprostatic extension of prostate cancer: a systematic review and diagnostic meta-analysis

<p>Apparent diffusion coefficient in extraprostatic extension of prostate cancer: a systematic review and diagnostic meta-analysis</p>

... extracted from included studies were quantitative assess- ments, and it has established the fact that compared to subjective analysis, objective assessment was prone to acquire higher sensitivity but at the cost of ...

13

Selenium and Vitamin E for Prostate Cancer: Post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) Status

Selenium and Vitamin E for Prostate Cancer: Post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) Status

... human PCa cell lines at a dose <10 μmol/L ...human PCa cells but not normal prostate cells in vitro, and (b) VES mod- ulates Fas signaling in PCa ...in PCa cells and suggested the ...

10

Optimizing prostate cancer accumulating model: combined PI-RADS v2 with prostate specific antigen and its derivative data

Optimizing prostate cancer accumulating model: combined PI-RADS v2 with prostate specific antigen and its derivative data

... of PCa and to monitor its aggressiveness ...in PCa detection is ...suffered PCa [27]. As a result, many men without cancer underwent unnecessary biop- sies, PCa cases were often ...

8

Artificial neural network (ANN) velocity better identifies benign prostatic hyperplasia but not prostate cancer compared with PSA velocity

Artificial neural network (ANN) velocity better identifies benign prostatic hyperplasia but not prostate cancer compared with PSA velocity

... all PCa patients even have decreasing PSA ...all PCa patients but stable or decreasing PSA values do not really reduce the risk of having PCa if the PSA alone is ...the PCa detection rate when ...

8

Show all 10000 documents...

Related subjects